---
title: Mettler Toledo (MTD) — intrinsic value and fair price
canonical: https://sweetvaluelab.com/stocks/mtd
ticker: MTD
as_of: 2026-10-17
sector: Healthcare
industry: Medical - Diagnostics & Research
---
# Mettler Toledo (MTD)

Mettler Toledo (MTD) closed at $1,622.29 on Oct 16, 2026, overvalued by 148% vs its model value of $653.22 (from a five-year discounted cash flow).

## Key figures

| Figure | Value |
| --- | ---: |
| Last close | $1,622.29 (Oct 16, 2026) |
| Model value (from a five-year discounted cash flow) | $653.22 |
| Price vs model | overvalued by 148% vs model |
| Range of that model | $434.50 – $1,253.73 |
| Market value | $32.5B |
| P/E (fiscal 2025) | 38.6 |
| Net margin (fiscal 2025) | 21.6% |
| Free cash flow (fiscal 2025) | $848.6M |
| Dividend yield (trailing twelve months) | 0.00% |
| Beta | 1.19 |
| Cost of capital (WACC) | 9.41% |
| Business classification | Mature & Stable (Low/slowing growth (~3% recent), High profitability (22% net margin), Moderately volatile earnings, High leverage (D/E 5.0x)) |

## On the stock lists

| List | Place | Figure | Page |
| --- | ---: | ---: | --- |
| Near 52-week highs | #35 | −1.0% | https://sweetvaluelab.com/lists/near-52-week-highs |

## Valuation models

Each model's value per share and the role the engine gave it for this business. The headline above is one model's value; every other model is listed with its own, and each has a page of its own under the valuation. Computed Oct 17, 2026.

| Model | Role | Value per share | Low | High |
| --- | --- | ---: | ---: | ---: |
| DCF · Perpetuity growth · 5y | primary | $653.22 | $434.50 | $1,253.73 |
| DCF · Perpetuity growth · 10y | cross check | $686.84 | $471.74 | $1,265.72 |
| DCF · EBITDA exit · 5y | cross check | $1,452.83 | $1,146.45 | $1,809.72 |
| DCF · EBITDA exit · 10y | cross check | $1,308.26 | $977.23 | $1,738.89 |
| P/E · peers | cross check | $1,602.98 | $1,432.92 | $2,255.94 |
| P/E · own history | cross check | $1,553.42 | $1,407.59 | $1,754.09 |
| PEG | sanity check | $526.48 | $526.48 | $526.48 |
| EV/EBITDA · peers | cross check | $1,454.20 | $1,328.59 | $1,547.40 |
| EV/Revenue · peers | cross check | $1,206.83 | $1,023.39 | $1,335.24 |
| Earnings power value | cross check | $0.00 | $0.00 | $0.00 |
| Dividend discount | cross check | $0.00 | $0.00 | $0.00 |

## Insider activity (SEC Form 4)

Past 90 days: 0 open-market buys ($0) and 5 open-market sales ($6.1M); 10b5-1 plan sales included.

| Date | Insider | Relationship | Transaction | Shares | Value |
| --- | --- | --- | --- | ---: | ---: |
| Aug 28, 2026 | SHUMAN-FABBRI NATALIA | Director | Grant / award | 16 | $0 |
| Aug 27, 2026 | Kaltenbach Patrick | President and CEO | Option/RSU exercise | 942 | $965,126.1 |
| Aug 27, 2026 | Kaltenbach Patrick | President and CEO | Open-market sell | 942 | $1.3M |
| Aug 27, 2026 | Kaltenbach Patrick | President and CEO | Option/RSU exercise | 942 | $0 |
| Aug 5, 2026 | SALICE THOMAS P | Director | Option/RSU exercise | 417 | $165,945.2 |

## Recent SEC filings

| Filed | Form | What | Filing |
| --- | --- | --- | --- |
| Aug 3, 2026 | 8-K | 5.02 Departure/Election of Directors or Officers; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits | https://www.sec.gov/Archives/edgar/data/1037646/000103764626000054/mtd-20260730.htm |
| Jul 31, 2026 | 10-Q | Quarterly report | https://www.sec.gov/Archives/edgar/data/1037646/000103764626000051/mtd-20260630.htm |
| Jul 30, 2026 | 8-K | 2.02 Results of Operations (Earnings); 9.01 Financial Statements and Exhibits | https://www.sec.gov/Archives/edgar/data/1037646/000103764626000049/mtd-20260730.htm |
| May 13, 2026 | 8-K | 5.02 Departure/Election of Directors or Officers | https://www.sec.gov/Archives/edgar/data/1037646/000103764626000026/mtd-20260507.htm |
| May 11, 2026 | 8-K | 5.07 Submission of Matters to a Shareholder Vote | https://www.sec.gov/Archives/edgar/data/1037646/000103764626000024/mtd-20260507.htm |

## Superinvestors holding it (latest 13F)

| Manager | Quarter | Shares | Value |
| --- | --- | ---: | ---: |
| Bridgewater | 2026-06-30 | 3,146 | $4.0M |
| Wallace Weitz | 2026-06-30 | 2,550 | $3.3M |
| Torray | 2026-06-30 | 1,671 | $2.1M |

3 tracked managers in all.

## About

Mettler-Toledo International Inc. (MTD) is a global enterprise dedicated to the production and provision of precision instruments and related services. The company's operations are strategically organized across five geographical divisions: its domestic U.S. market, Swiss operations, Western European activities, Chinese operations, and an 'Other' segment covering remaining territories. Their extensive product portfolio serves diverse scientific and industrial needs. Within the laboratory sphere, Mettler-Toledo supplies a comprehensive array of equipment, including high-precision balances, advanced liquid handling systems (such as pipetting solutions), automated laboratory reactors, titrators, pH meters, sensors and analyzers for process analytics, instruments for evaluating physical properties, thermal analysis systems, and various other analytical tools. These hardware offerings are com…

---

Source: https://sweetvaluelab.com/stocks/mtd (SweetValueLab, free, no account). Prices and statements from Financial Modeling Prep; filings from SEC EDGAR. Research and educational data, not investment advice; nothing here is a recommendation to buy, sell or hold any security.